The ILLUMINATE Studies are phase 2 clinical research studies evaluating an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
Continue ReadingConsider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.
Continue ReadingJoin the Solutions for Celiac Study where you get access to blood testing, symptom tracking tools, and celiac specialists focused on your disease.
Continue ReadingAs we head into fall, I am happy to share that our 2023 Virtual Turkey Trot is right around the corner – and our team is gearing up for a terrific event! As our biggest annual fundraiser helping to fund the research, advocacy, and education that moves us toward treatments...